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A B S T R A C T
Bone graft substitutes and bone void ﬁllers are predominantly used to treat bone defects and bone fusion in
orthopaedic surgery. Some aragonite-based scaﬀolds of coralline exoskeleton origin exhibit osteoconductive
properties and are described as useful bone repair scaﬀolds. The purpose of this study was to evaluate the in vitro
osteogenic potential of the bone phase of a novel aragonite-based bi-phasic osteochondral scaﬀold (Agili-C™,
CartiHeal Ltd.) using adult human bone marrow-derived mesenchymal stem cells (MSCs). Analyses were per-
formed at several time intervals: 3, 7, 14, 21, 28 and 42 days post-seeding. Osteogenic diﬀerentiation was
assessed by morphological characterisation using light microscopy after Alizarin red and von Kossa staining, and
scanning electron microscopy. The transcript levels of alkaline phosphatase (ALP), runt-related transcription
factor 2 (RUNX2), bone gamma-carboxyglutamate (BGLAP), osteonectin (SPARC) and osteopontin (SPP1) were
determined by quantitative PCR. Proliferation was assessed by a thymidine incorporation assay and proliferating
cell nuclear antigen (PCNA) immunocytochemistry. Our results demonstrate that the bone phase of the bi-phasic
aragonite-based scaﬀold supports osteogenic diﬀerentiation and enhanced proliferation of bone marrow-derived
MSCs at both the molecular and histological levels. The scaﬀold was colonized by diﬀerentiating MSCs, sug-
gesting its suitability for incorporation into bone voids to accelerate bone healing, remodelling and regeneration.
The mechanism of osteogenic diﬀerentiation involves scaﬀold surface modiﬁcation with de novo production of
calcium phosphate deposits, as revealed by energy dispersive spectroscopy (EDS) analyses. This novel coral-
based scaﬀold may promote the rapid formation of high quality bone during the repair of osteochondral lesions.
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1. Introduction
The repair of joint lesions requires the reconstruction of both sub-
chondral bone and articular cartilage. This challenging goal might be
achieved by certain novel bi-phasic osteochondral scaﬀolds capable of
stimulating both articular cartilage regeneration and subchondral bone
repair. The intrinsic properties of the scaﬀold at the bony phase ought
to be designed speciﬁcally to introduce structural, biological and bio-
mechanical cues into the aﬀected regions (Bowland et al., 2015). The
optimal osteogenic scaﬀold should therefore allow bone repair in da-
maged areas by means of migration, proliferation and osteogenic dif-
ferentiation of mesenchymal stem cells (MSCs) into the graft (Ciocca
et al., 2015).
Multiple types of bony scaﬀolds are available, including calcium
phosphate and calcium carbonate, and various combinations of both
materials (Niu et al., 2015). Bone-like nanocomposite scaﬀolds made of
sericin (a silk worm-protein) and hydroxyapatite crystals promote the
osteogenic diﬀerentiation of human bone marrow-derived mesench-
ymal stem cells (BM-MSCs) (Yang et al., 2015a,b). Biomineralized hy-
droxyapatite small intestinal submucosa scaﬀolds were found to pro-
mote the osteogenic diﬀerentiation of MSCs in basal media without
osteogenic supplements due to the presence of hydroxyapatite crystals
in the scaﬀolds (Yang et al., 2015a,b). In a diﬀerent approach, hydro-
xyapatite disks functionalised with a modular peptide formed of a hy-
droxyapatite-binding peptide motif and an osteogenic peptide motif
were documented to induce the osteogenic diﬀerentiation of MSCs
(Polini et al., 2014). To facilitate scaﬀold vascularisation and in-
corporation, a novel strategy involving a “smart matrix” composed of
three key components (RGD-phage; porous bone-like biphasic calcium
phosphate scaﬀold and MSCs) has been developed. Due to the presence
of the RGD-phage nanoﬁbres, the novel matrix can regulate endothelial
cell migration and adhesion to induce vascularisation and simulta-
neously activate osteoblastic diﬀerentiation of MSCs, and thus induce
both osteogenesis and angiogenesis in vivo (Wang et al., 2014).
Some of the scaﬀolds used clinically are coralline aragonite-based.
The aragonite (a crystalline form of calcium carbonate) exoskeletons of
certain coral species (marine invertebrates from the class Anthozoa of
the phylum Cnidaria) are remarkably similar to human spongy bone
with respect to its 3D structure, as well as macro- and micro-porosity
and pore interconnections (Demers et al., 2002). These coralline cal-
cium carbonate scaﬀolds have been shown to be biocompatible, os-
teoconductive, and biodegradable when used as bone grafts
(Ripamonti, 2017); however, there is a controversy in the literature
regarding the mechanism by which coral grafts transform into bone and
three mechanisms are proposed.
The ﬁrst hypothesis assumes that the coral graft is osteoinductive
(Ripamonti et al., 2009); immature undiﬀerentiated (stem) cells are
recruited and the coral graft stimulates these cells to diﬀerentiate into
pre-osteoblasts (Albrektsson and Johansson, 2001). A second me-
chanism has also been described by which the coral substrate acts
merely as an osteoconductive material; osteoconduction is bone growth
on a scaﬀold surface caused by the action of diﬀerentiated bone cells,
which may include pre-existing pre-osteoblasts/osteoblasts activated by
trauma, or cells recruited from mesenchymal cells by osteoinduction
(Albrektsson and Johansson, 2001). Recently, certain bone substitute
materials were reported to demonstrate a mixture of properties being
both osteoinductive and osteoconductive (Conserva et al., 2013). A
third mechanism, osteotransduction (Driessens et al., 1998), has been
suggested for certain biomaterials consisting mostly of calcium phos-
phate that allow gradual reabsorption and replacement by newly
formed functional bone tissue. Bone formation occurs by direct de-
position of bone trabeculae on the scaﬀold material, which is similar to
the clinically described mechanism of primary bone repair (Marsell and
Einhorn, 2011).
The cell-free, bi-phasic aragonite-based scaﬀold (Agili-C™, CartiHeal
Ltd.) used in this study is a biocompatible, resorbable material. The
scaﬀold has been previously shown to be supportive of cartilage and
bone repair in human patients (Scott, 2011). Agili-C™ is indicated for
the treatment of osteochondral defects, in both inﬂammatory and non-
degenerative joints. This scaﬀold is made of a composite material,
which is intended to help restore the osteochondral unit through the in
situ regeneration of both articular cartilage and its underlying sub-
chondral bone, and to help reproduce the original structure and func-
tion of the aﬀected tissues. The scaﬀold does not only eﬀectively sti-
mulate cartilage regeneration and repair ex vivo (Chubinskaya et al.,
2018) but its suitability to facilitate osteochondral regeneration in vivo
has been demonstrated in a caprine model (over a 6–12-month follow-
up period), and also in humans (Kon et al., 2014a,b, 2015; Kon et al.,
2016).
In the current study we examined the in vitro mechanisms induced
by the bone phase of the Agili-C™ scaﬀold on the osteogenic diﬀer-
entiation of BM-MSCs cultured under diﬀerentiation-inducing condi-
tions. BM-MSCs are multipotent and can diﬀerentiate into diﬀerent cell
lineages, such as adipocytes, myocytes, chondrocytes, or osteoblasts,
depending on the composition and 3D organization of the extracellular
matrix (ECM) and the combined eﬀect of growth factors and other
morphogens in their immediate environment (Pittenger et al., 1999).
We present data on enhanced osteogenesis of BM-MSCs seeded onto
the scaﬀold and cultured under osteogenic conditions. The key ob-
servation of this study is that the phenomenon of de novo formation of
calcium phosphate depositions on the aragonite scaﬀold surface in vitro
by BM-MSCs has not been previously observed on the Agili-C™ scaﬀold.
We show that the coral-derived aragonite scaﬀold has an ultrastructure
and pore size similar to that of spongy bone, which favours os-
teoinduction, osteoconduction and potentially osteotransduction.
2. Methods
2.1. Experimental setup
The study was designed to evaluate the eﬀect of the bone phase of
Agili-C™, a coral-derived aragonite scaﬀold, on human BM-MSCs com-
pared to cells grown in an osteogenic diﬀerentiation medium without
scaﬀolds. The eﬀect of the scaﬀold exposure was evaluated by pro-
liferation assays, phenotypic assessment and gene expression assays to
deﬁne scaﬀold-enhanced diﬀerentiation towards the osteogenic
pathway. Scaﬀold-exposed cultures (SEC) were compared to control
cultures (CC) grown in osteogenic diﬀerentiation medium (Thorpe
et al., 2016).
2.2. Aragonite-based scaﬀold
The aragonite-based scaﬀold (Agili-C™, CartiHeal 2009 Ltd, Kfar
Sava, Israel) is derived from the Porites species and characterised by
interconnected pores with a mean pore diameter of 150 μm (range
100–300 μm) and ∼50% porosity (Wu et al., 2009) (Fig. 1). Scaﬀold
samples were provided by the manufacturer. Dimensions of the scaﬀold
cylinders were as follows: Ø=6mm; height, 2 mm; the cylinders were
taken from a serial production stock and contained the mineral phase
only.
2.3. Cell cultures
Commercially available primary adult human BM-MSCs were used
(Lonza Group Ltd., Basel, Switzerland). Cells were expanded in T75 cell
culture ﬂasks (Orange Scientiﬁque, Braine-l’Alleud, Belgium) in hMSC
Growth Medium (MSCGM™ Mesenchymal Stem Cell Growth Medium,
Lonza). 1 mL aliquots (containing∼700,000 cells from passage 3) were
frozen and stored in liquid nitrogen according to the manufacturer's
instructions. For each experiment, one vial (always from passage 3) was
thawed and cells were expanded in four T75 ﬂasks until ∼90% con-
ﬂuence (which took 10–14 days). Cells were detached using Trypsin/
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EDTA for MSC (Lonza), centrifuged at 600×g for 5min, and re-
suspended. The cell suspension (20,000 cells/cm2) was seeded onto
scaﬀolds placed in 24-well cell-culture plates (Orange Scientiﬁque)
with round cover glasses (Ø= 10mm; thickness=No.1; Menzel-
Gläser, Menzel GmbH, Braunschweig, Germany). Controls were seeded
directly onto coverslips without the scaﬀolds in a single droplet.
Following a 2 h adherence period cultures were fed with growth
medium (MSCGM™). At 24 h post seeding, medium was changed to
osteogenic diﬀerentiation medium (hMSC Osteogenic Diﬀerentiation
BulletKit™ Medium, Lonza). Cultures on various days were subject to
analyses. For histological staining procedures, cells attached to the
coverslips in the vicinity of the scaﬀold were used, due to the fact that
cells growing inside the scaﬀolds would have been impossible to ana-
lyse using light microscopy.
2.4. Phenotypic conﬁrmation of bone marrow-derived MSCs
Flow cytometry was used for phenotyping the adult bone marrow-
derived MSCs, to rule out de-diﬀerentiation. Cells were analysed from
passage 3. The following haematopoietic and mesenchymal stem cell
surface markers were assessed: CD29/Integrin β1, CD34, CD47, CD73,
CD90/Thy-1 (Biolegend, San Diego, CA, USA); CD45, CD146/
Melanoma cell adhesion molecule (MCAM), CD117/c-kit (R&D
Systems, Minneapolis, MN, USA) and CD105/Endoglin (BD Biosciences,
San Jose, CA, USA). Cells cultured in a monolayer were harvested with
0.025% trypsin/EDTA, washed twice with Fluorescence-Activated Cell
Sorting (FACS) buﬀer (0.5% bovine serum albumin and 0.05% Na-azide
dissolved in PBS), incubated with the selected antibodies (according to
the manufacturer's protocol) on ice for 30min, then washed with FACS
buﬀer and measured by a FACSCalibur ﬂow cytometer (BD Biosciences,
Franklin Lakes, NJ, USA). Data were analysed using FlowJo LLC Data
Analysis Software (Ashland, OR, USA). Results are expressed as means
of positive cells (%).
2.5. Histological procedures
1. Investigation of cellular morphology with conventional haematox-
ylin and eosin (H&E) staining
Cultures were maintained up to 42 days and assessments were
carried out on days 14, 28, 35 and 42 post-seeding. In brief, cultures
were washed with phosphate buﬀered saline (PBS) and ﬁxed with a 4:1
mixture of absolute ethanol and 4% formaldehyde (Sigma-Aldrich, St.
Louis, MO, USA). After rehydration in a descending series of ethanol,
cells were stained with Gill's haematoxylin No. 2 and eosin Y (1%
aqueous solution; Bio Optica Milano S.p.A., Italy). Cultures were ﬁrst
immersed in haematoxylin for 20 s, rinsed in running tap water for
5min, and after washing in distilled water, eosin was applied for 2min.
Eosin was removed and cultures were dehydrated in ascending series of
ethanol, and after a ﬁnal wash in xylene, colonies were mounted onto
glass slides using DPX mounting medium (Sigma-Aldrich).
Photomicrographs of the cultures were taken using an Olympus DP72
camera on a Nikon Eclipse E800 microscope (Nikon Corporation,
Tokyo, Japan), and images were prepared using cellSens 1.5 software
(Olympus, Japan).
2. Assessment of matrix mineralisation by Alizarin Red S staining
To demonstrate the extent of matrix calciﬁcation the cultures were
ﬁxed with the same ﬁxative as above on various days of culturing, then
stained for 2min with 2% (w/v) Alizarin Red S (Sigma-Aldrich) dis-
solved in distilled water and pH was adjusted with 10% ammonium
hydroxide to pH 4.2. Excess dye was removed, then the coverslips were
dipped into acetone (20 times) for dehydration, and then into acet-
one–xylene (1:1) mixture (20 times). Coverslips were ﬁnally mounted
onto glass slides using DPX mounting medium (Sigma-Aldrich).
Photomicrographs of the cultures were taken as described above.
3. Assessment of matrix mineralisation by von Kossa staining
As an alternative method, matrix mineralisation was also assessed
by von Kossa staining. Formalin and ethanol-ﬁxed cultures were in-
cubated with 1% silver nitrate and placed under UV light for 10min,
rinsed in distilled water, and unreacted silver was removed with 5%
sodium thiosulphate for 5min. After rinsing in distilled water, speci-
mens were counterstained with 0.1% nuclear fast red solution for 5min.
Finally, samples were dehydrated through graded ethanol, and
mounted using DPX mounting medium. Photomicrographs of the cul-
tures were taken as described above.
2.6. Cell proliferation assays
Radioactive thymidine incorporation assay was performed on cul-
turing days 3, 7, 14, and 21 in 3 independent experiments. Cell culture
medium containing 1 μCi/mL 3H-thymidine (185 GBq/mM 3H-thymi-
dine, Amersham Biosciences, GE Healthcare UK Ltd, Little Chalfont,
UK) was added to the wells for 48 h. After washing with PBS, proteins
were precipitated with ice-cold 5% trichloroacetic acid, and washed
with PBS again. Then, trypsin-digested cell lysates were transferred to
special, opaque 96-well microtiter plates (Wallac, PerkinElmer Life and
Analytical Sciences, Shelton, CT, USA). Samples were air-dried for
2 weeks at room temperature and radioactivity was counted by a
Chameleon liquid scintillation counter (Hidex Oy, Turku, Finland).
Proliferating cell nuclear antigen (PCNA) immunocytochemistry
was used to visualise proliferating cell topology within the cultures in 3
independent experiments. 14-day-old scaﬀold (SEC) and control cul-
tures (CC) were used. Samples were ﬁxed with a 4:1 mixture of absolute
ethanol and 40% formalin for 30min, followed by permeabilization
with ice-cold methanol for 10min at−20 °C. After washing the cultures
with PBS, speciﬁc binding sites were blocked for 1 h in PBS containing
5% normal goat serum and 0.3% Triton X-100. Thereafter, samples
were incubated with the PCNA primary antibody (Cell Signaling
Technology Inc, Davers, MA, USA) at a dilution of 1:2,400 in blocking
buﬀer overnight at 4 °C. After washing, the secondary antibody (Alexa
Fluor® 555 Goat anti-mouse IgG; A21422; Life Technologies, Carlsbad,
CA, USA) was applied at a dilution of 1:1,500 in PBS for 1 h at room
temperature. Subsequently, specimens were washed with PBS and
covered with anti-fade medium containing DAPI (Vectashield mounting
medium; Vector Laboratories, Peterborough, England).
Photomicrographs were taken by an Olympus DP72 camera on a Nikon
Eclipse E800 microscope (Nikon Corporation). Images were acquired
using cellSens Entry 1.5 software (Olympus). Proliferating cells were
Fig. 1. SEM micrograph of the porous 3D structure of the aragonite scaﬀold
used in this study. Scale bar, 1mm.
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counted using the Automatic Nuclei Counter plug-in for ImageJ
(downloaded from https://imagej.nih.gov/ij/plugins/itcn.html) fol-
lowing the analysis of 3–3 images taken from each experiment.
2.7. Sample preparation for scanning electron microscope (SEM) analysis
Aragonite-based scaﬀolds removed from cell cultures on various
days of culturing were ﬁxed with a 4:1 mixture of absolute ethanol and
4% formaldehyde. After 30min, the ﬁxative was washed with 80%
ethanol. Samples were then rinsed and stored in 70% ethanol at
−20 °C. 3 successive washes were performed with increasing series of
ethanol (90%, 95% and 100%) for 10min. The scaﬀolds were dried by
successive washes with 0.2mL hexamethyldisilazane (HMDS) at con-
centrations of 33%, 50%, and 67% for 1min each. A last wash was
performed with 0.2mL of 100% HMDS 3× for 1min. The solution was
removed and samples were left to dry in the chemical hood overnight.
2.8. Scanning electron microscopy
SEM (JEOL Ltd., Tokyo, Japan - JSM 35 CF) analyses were per-
formed at Ariel University, Israel. Each specimen was glued to a
mounting stab, coated with gold and observed at 15–20 keV. Elemental
analysis (SEM-EDS) was performed using the same instrumentation.
2.9. Gene expression analyses using RT-qPCR
Relative gene expression levels of alkaline phosphatase (ALP), runt-
related transcription factor 2 (RUNX2), bone gamma-carboxyglutamate
(BGLAP), osteonectin (secreted protein, acidic, rich in cysteine or
SPARC) and osteopontin (SPP1) genes were determined by RT-qPCR
measurements using an Applied Biosystems™ QuantStudio™ 12K Flex
Real-Time PCR System (Life Technologies, CA, USA). The Universal
Probe Library (UPL) Assay Design Center (Roche, Bazel, Switzerland)
was used to design speciﬁc primer pairs. The sequences used for am-
pliﬁcations were as follows: ALP (FW: 5′– TCA CTC TCC GAG ATG GTG
GT –3′, Rev: 5′–GTG CCC GTG GTC AAT TCT–3′, UPL: #12); BGLAP
(FW: 5′–GAA GAG ACC CAG GCG CTA C–3′, Rev: 5′–CTC ACA CAC CTC
CCT CCT G–3′, UPL: #45); RUNX2 (FW: 5′–GGC GCA TTT CAG ATG
ATG A–3′, Rev: 5′–GCC CAG TTC TGA AGC ACC T–3′, UPL: #87);
SPARC (FW: 5′–TTC CCT GTA CAC TGG CAG TTC–3′, Rev: 5′–AAT GCT
CCA TGG GGA TGA–3′, UPL: #36); SPP1 expression was measured
using IDT PrimeTime assay (ID: Hs.PT.58.19252426). For data nor-
malization the following three reference genes were tested:
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), assay code:
Hs99999905_m1; peptidyl-prolyl isomerase A (PPIA), assay code:
Hs99999904_m1; and hypoxanthine phosphoribosyl-transferase 1
(HPRT1), assay code: Hs03929098_m1 (Life Technologies).
On various days of culturing, cell cultures (a total of 3 per group and
per culturing day) were dissolved in Trizol (Applied Biosystems, Foster
City, CA, USA), total RNA was harvested in RNase-free water, and
stored at−80 °C. First strand cDNA was generated from 1 μg total RNA
using the High Capacity cDNA Reverse Transcription Kit (Life
Technologies). RT-qPCR measurements were performed in an ABI Prism
7900 Real-Time PCR System (Life Technologies) in 96-well plates using
2×TaqMan Gene Expression Master Mix (Life Technologies), with the
following thermal cycling conditions: enzyme activation at 95 °C for
1min, followed by 40 cycles of denaturation at 95 °C for 12 s and an-
nealing/extension at 60 °C for 45 s.
To ﬁnd the best normalising gene, standard deviations of gene ex-
pression levels of reference genes were calculated between samples, and
PPIA was found to show the lowest standard deviation values.
Therefore, PPIA expression was used to determine relative gene ex-
pression levels, which were calculated by the comparative Ct method.
In the comparative or ΔΔCt method of qPCR data analysis, the Ct values
obtained from two diﬀerent experimental RNA samples are directly
normalized to the reference gene (PPIA) and then compared.
Hierarchical cluster analysis based on the relative expression levels of
selected genes was performed by the R software package.
2.10. Statistical analysis
All data are representative of at least three independent experi-
ments. Where applicable, data are expressed as mean ± SD. Data was
tested for normality using the Kolmogorov-Smirnov test and then sta-
tistical analysis was performed by two-way ANOVA using the all-pair-
wise multiple comparison procedure (Holm-Sidak method). Statistical
analyses were performed using SigmaStat version 3.5. The level of
signiﬁcance was set as follows: *P < 0.05; **P < 0.01.
3. Results
3.1. Validation of the mesenchymal stem cell phenotype
To rule out potential phenotypic changes during culture, cells re-
trieved from frozen aliquots were immunophenotypically evaluated.
Cells cultured in growth medium maintained the expression of cell
Fig. 2. CD marker expression analysis and immunophenotypic characterisation of hMSCs expanded in growth medium using FACS.
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surface markers characteristic to hMSC; they were found to be positive
for CD90, CD73, CD105, CD146, CD47 and CD29; and negative for
CD45, CD117 and CD34 (Dominici et al., 2006) (Fig. 2). Expressions of
CD105, CD73 and CD90 are characteristic for MSCs, lack of CD45
proved the absence of leukocytes, and no staining for CD117 and CD34
conﬁrmed the absence of haemopoietic stem cells and endothelial cells
from the cell culture. These results conﬁrmed that the human cells used
in the study fulﬁlled the minimal criteria of multipotent MSCs, a
property that was preserved during the entire expansion period.
3.2. Cell culture morphology visualized by H&E staining
On day 0 the cells exhibited typical mesenchymal morphology
forming a monolayer culture composed of spindle-shaped cells (Fig. 3).
Diﬀerences in cellular morphology were noted between the SEC and the
CC groups at later time points (e.g. on day 14 as shown in Fig. 3). A
spatial zonation phenomenon occurred in the SEC group depending on
the proximity to the scaﬀold material starting from day 14. Cells in
direct contact with the scaﬀold and/or its fragments attached to the
scaﬀold surface with numerous cellular podia. They had large, oval-
shaped nuclei and a rather basophilic cytoplasm, indicating active
protein synthesis. The cells located in the more peripheral zone
(average zone width about 150 μm) were cuboidal and formed multi-
layers around the scaﬀold. The morphology of the latter cell population
also demonstrated features of active protein synthesis. Farther away
from the scaﬀold the morphology of the SEC cultures was quite similar
to the CC cultures with spindle shaped monolayer cells predominating.
Both CC and SEC cultures exhibited a temporal series of sequential
morphological stages. In SEC cultures, during the ﬁrst stage (by day
14), cells became thicker and shorter but still spindle shaped. Their
cytoplasm was more basophilic than prior to osteogenic induction, and
possessed a euchromatic, large, oval shaped nucleus. At a later stage (at
28 days), the majority of CC cells became larger and changed their
morphology to cuboidal or polygonal. Most of the cells were char-
acterised by large spherical nuclei. Later, multilayer formation occurred
mainly in the SEC cultures with the appearance of small basophilic
nodules that gradually coalesced (in CC cultures complete coalescence
was not achieved during the 42-day-long culture period). This stage was
also characterised by a robust production of ECM by the cells. The SEC
group cultures demonstrated an accelerated diﬀerentiation process as
compared to the CC group.
3.3. Culture mineralisation
Alizarin Red (AR) staining was used to demonstrate the presence of
mineralised (calciﬁed) matrix areas in BM-MSC cultures. There was a
massive mineralisation in SEC cultures, whilst only weak staining was
observed in CC cultures by day 21 (Fig. 4A). The deposition of inorganic
calcium salts was the most prominent directly surrounding the scaﬀolds
and a more heavily AR-positive mineralised area was visible in the
peripheral region of cultures with the aragonite scaﬀolds. Control cul-
tures showed little increase in AR-positivity over time (primarily at the
edge of the droplet culture), while those with the scaﬀolds exhibited a
prominently increased calciﬁcation by day 42. Stronger von Kossa
staining also indicated a more intense biomineralisation in the SEC
cultures than in CC cultures (Fig. 4B).
3.4. SEM analysis
To investigate cell adhesion on the scaﬀold, as well as to better
Fig. 3. Changes in cell morphology of hMSCs cultured in osteogenic medium in
the presence and absence of aragonite scaﬀold, for 14, 28 and 35 days (H&E
staining). CC-Control Culture (left), SEC-Scaﬀold Exposed Culture (right).
Original magniﬁcation, 20×; scale bar, 100 μm for all images. Arrows indicate
small fragments of the scaﬀold and the increased density of cells around them.
Fig. 4. A. Calciﬁed matrix depositions in hMSCs cultured in osteogenic medium
for 21, 28, 35 and 42 days. Calciﬁed matrix depositions were visualized with AR
staining (reddish-brown areas). The positions of the implants after their re-
moval (see SEC row) are labelled with asterisks (*). Images are representative of
four independent experiments. Scale bars, 1 mm for all images. The circular
contours in the control (CC) row represent the edges of droplets in which the
cells were seeded on day 0. B. hMSCs cultured in osteogenic medium for 28
days. Calcium and phosphate salt-containing deposits were visualized with von
Kossa staining on culturing day 28. Mineralised matrix depositions are visible as
black-grey precipitations. Specimens were background stained using nuclear
fast red. Original magniﬁcation, 20×; scale bars, 100 μm for both images. (For
interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the Web version of this article.)
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characterise the newly formed ECM secreted by the diﬀerentiating
MSCs, SEM analyses were performed. hMSCs adhered and spread on the
surface of the scaﬀold by forming a thick layer of cells covering the
pores of the scaﬀold as early as day 14 (Fig. 5). The complexity of the
tissue-like multilayer culture was observed to grow with time until the
coral surface was almost completely covered by day 28.
Scanning the scaﬀold surface at certain locations and at higher
magniﬁcations revealed the presence of a microstructure deposit ex-
hibiting a unique morphology, not typical of natural aragonite (Fig. 6;
day 0 representing the typical aragonite surface, compared to days
14–28). This deposit exhibited increased complexity over time, begin-
ning as a rather ﬂat surface at day 14 and culminating in a rough hill-
like topology at day 28 (Fig. 6A). Energy dispersive spectroscopy (EDS)
analysis of the deposit identiﬁed the presence of phosphate 14 days
post-seeding (Fig. 6B). In the natural aragonite, no phosphate peak was
observed (Fig. 6B inset). The morphology of these deposits at this time
point was similar to the typical calcium phosphate microstructures
(Kazemzadeh-Narbat et al., 2010).
SEM analysis revealed cells adhering to the deposited calcium
phosphate layer as well as cells covered by spherical deposits (Fig. 7).
These were shown by EDS to be calcium phosphate and morphologi-
cally similar to typical hydroxyapatite bundles (Scaglione et al., 2008).
The surface deposition and substitution of the natural aragonite scaﬀold
by phosphate into a material which can be similar to hydroxyapatite
present in the inorganic phase of bone can make these scaﬀolds an ideal
cell adhesion material.
3.5. Proliferation rate
The proliferation rate of the hMSCs was assessed by incubating the
cultures with 3H-thymidine-containing osteogenic diﬀerentiation
medium for 48 h. Cells in SEC cultures exhibited a signiﬁcantly in-
creased proliferation rate on days 3, 7 and 14, but no signiﬁcant dif-
ference could be detected by day 21 relative to control (Fig. 8A).
Given the detected increase in proliferation in the SEC population,
we wanted to rule out a potential artifact caused by the increased
culture area (as the scaﬀolds oﬀer a larger 3D surface for the cells to
expand on). Therefore, to examine the spatial distribution of pro-
liferating cells, PCNA immunocytochemistry was performed on 14-day-
old cultures. In dividing cells, PCNA was clearly localised in the nu-
cleus. Cells in the SEC culture located close to the scaﬀold or its frag-
ments on the coverslip displayed higher PCNA levels compared to CC
cultures or to cells of the SEC cultures located at a distance greater than
∼150 μm from the scaﬀold (Fig. 8B). Cell counting revealed an approx.
three-fold increase in the number of dividing cells in the SEC cultures
(14.17% ± 6.83 in CC vs. 49.08% ± 22.42 in SEC). These ﬁndings
clearly indicate a stimulating eﬀect of the scaﬀold on the proliferation
rate of hMSCs.
3.6. Expression of osteogenic marker genes in the presence of the Agili-C™
scaﬀold
The relative mRNA expression levels of the osteogenic marker genes
alkaline phosphatase (ALP), bone gamma-carboxyglutamate (BGLAP;
osteocalcin), runt-related transcription factor 2 (RUNX2), osteonectin
(SPARC) and osteopontin (SPP1) were monitored at an early (7-day)
and a late (28-day) time point using RT-qPCR (Fig. 9).
RUNX2 was upregulated on day 7 in the SEC culture compared to
the CC cultures. It was downregulated by day 28 in the SEC culture,
while expression was constant at both time points in CC cultures.
Alkaline phosphatase expression was similar in SEC and CC cultures at
both time points. Osteopontin mRNA (SSP1) was upregulated in control
cultures by day 28, and peaked in the SEC culture on day 28 (7.9-fold
increase, *P=0.004). In both cultures, BGLAP expression showed a
strong downregulation by day 28 compared to day 7. SPARC transcript
levels in SEC culture exhibited a similar downregulation pattern over
time to those of BGLAP (4.36-fold change, *P=0.007); however, it
maintained a steady expression in the control CC culture.
Hierarchical clustering of gene transcripts revealed groups based on
overall gene expression patterns of the studied marker genes. The
clustering clearly separated the 7-day control cultures, and showed that
the 7-day SEC cultures were more related to the 28-day cultures (both
CC and SEC), implicating a more advanced osteogenic gene expression
pattern caused by the scaﬀold even at this early stage (Fig. 9F).
4. Discussion
Tissue engineering requires either the introduction of cells capable
of reconstructing the tissue (Mesallati et al., 2015) or the recruitment of
such cells either from local or systemic sources (Fermor et al., 2015).
Based on their favourable structural nanoscale characteristics and their
osteoconductive properties, coral-based aragonite constructs are an
emerging bone graft substitute and bone void ﬁller in orthopaedic
surgery, cranial and maxillofacial reconstruction, spine fusions and
periodontal surgery. Following implantation, aragonite-based bioma-
terials are gradually reabsorbed and replaced by the newly generated
bone tissue (Chiroﬀ et al., 1975; Guillemin et al., 1987; Ohgushi et al.,
1992; Olah and Borbas, 2008). In order to better understand the me-
chanism of osteoinduction by the coral scaﬀolds, several in vitro and in
vivo studies have been performed. MSC-seeded biodegradable coralline
Fig. 5. SEM images of cell layer growth on aragonite scaf-
folds after 14, 21 and 28 days. A and D. Day 14 showing
incomplete cell layer coverage. B and E. Day 21 showing
almost complete cell layer coverage. C and F. Day 28
showing complete and complex cell layer formation. For
images A, B and C, original magniﬁcation was 30× (scale
bar, 1 mm). For D, E and F, original magniﬁcation was
10,000× (scale bar, 1 or 2 μm as shown).
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hydroxyapatite/calcium carbonate composite scaﬀolds implanted into
an immunodeﬁcient mouse model or into human patients as void ﬁllers
appeared to be an excellent biodegradable in vivo bone graft material as
they biointegrate with the host and induce osteoconduction (Harris and
Cooper, 2004; Fu et al., 2013). The in vitro osteogenic capacity of coral-
based hydroxyapatite and aragonite scaﬀolds with MSCs of varied ori-
gins has been evaluated by an array of SEM, ﬂuorescent microscopic
and transcriptional analyses (Al-Salihi and Samsudin, 2004; Mygind
et al., 2007; Figueroa et al., 2011; Puvaneswary et al., 2013), but none
of these studies used such a wide set of methodology that is presented in
this work. Also, to the best of our knowledge, a comprehensive study on
the molecular background of the osteogenic cell diﬀerentiation poten-
tial of the Agili-C™ scaﬀold using BM-MSCs has not yet been carried out.
The current in vitro study aimed to elucidate the mechanism of ac-
tion underlying bone regeneration induced by the bone phase of the
Agili-C™ aragonite-based scaﬀold. We ﬁrst characterised the mor-
phology (porosity and pore size) of the scaﬀold using SEM analysis,
which revealed that the pores in the scaﬀold were interconnected, the
mean pore diameter was 150 μm (range 100–300 μm) and porosity was
∼50%; these features were remarkably similar to bone grafts
(Puvaneswary et al., 2013). According to the basic assumption that the
cells that ﬁrst enter the scaﬀold upon implantation are from the bone
marrow, we used commercially available primary adult human bone
marrow-derived MSCs for this work, which have the potential to dif-
ferentiate towards the osteogenic lineage (Pittenger et al., 1999).
Osteotransduction, the process whereby after implantation into
bone in vivo, the scaﬀold material is transformed into new bone tissue,
is known to occur to a limited extent in calcium phosphate bone ce-
ments (Driessens et al., 1998) due to direct cell attachment to the
surface. The degree of osteotransduction may depend on the avail-
ability of dicalcium phosphate anhydrous (DCP) and CaCO3 in the ce-
ment and can be signiﬁcantly (up to 50%) enhanced with the addition
of TGF-β1 (Blom et al., 2001). As the scaﬀold used in this study is
composed of 98% calcium carbonate, a part of the surface should be
transformed into calcium phosphate for enhanced biocompatibility.
Our SEM analyses demonstrated the presence of newly formed calcium
phosphate deposition on the surface of the aragonite-based scaﬀolds
(either as a result of osteoconduction or osteotransduction). These de-
posits grew in complexity with the passage of time and SEM analysis
demonstrated direct cell adherence to this newly formed surface layer.
Moreover, the presence of the coralline scaﬀold enhanced the pro-
liferation of MSCs and the formation of multilayer cultures on its sur-
face. The proliferation rate was higher in the SEC cultures as compared
to CC cultures. At the same time, based on histological and gene
Fig. 6. A. SEM images showing the formation of the complexed microstructure deposits over time (0, 14, 21, and 28 days) exhibiting a calcium phosphate-like unique
morphology. Day 0 represents the typical surface morphology of natural aragonite scaﬀold. Scale bar, 1 μm for all images. B. SEM-EDS elemental analysis of the
deposit layer formed on the aragonite surface area 14 days post-seeding. The phosphate peak (2.31% weight) is marked with a circle. Insert – EDS spectrum of
natural aragonite showing absence of phosphate.
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expression analyses, osteoblastic diﬀerentiation appeared to progress
more rapidly in the scaﬀold-exposed culture compared with stem cell
cultures grown without scaﬀolds in osteogenic diﬀerentiation medium.
The diﬀerentiation sequence was similar in both cultures, but all stages
took place earlier in the presence of the scaﬀolds.
The mRNA levels of several classic osteogenic genes such as RUNX2,
ALP and SPP1 were enhanced by the presence of the scaﬀold. RUNX2 is
an essential transcriptional factor for the activation of osteoblast-asso-
ciated genes, and is therefore an important early indicator of osteoblast
diﬀerentiation and bone formation (Ducy et al., 1997). RUNX2 directly
activates the transcription of genes such as osteocalcin (BGLAP), os-
teopontin (SPP1), collagen type I, bone sialoprotein, or alkaline phos-
phatase (ALP). A 4-fold upregulation was reported by Birk and collea-
gues just 1 h after cell seeding in 3T3F442A preadipocytes seeded onto
coralline scaﬀolds (Birk et al., 2006). The current study did not examine
such early time points. The detected RUNX2 expression pattern in
scaﬀold-exposed cells (SEC) was more pronounced than that of controls
(CC) by day 7 of culturing, and declined by day 28. RUNX2 is typically
downregulated in 3 or 4-week-old cultures (Wu et al., 2014). This
downregulation is an important indicator of matrix maturation and
mineralisation. The lack of downregulation observed in the CC cultures
probably indicates a delay or lack of matrix mineralisation. Indeed, von
Kossa staining indicated that the extent of mineralisation was more
advanced in the SEC cultures compared with CC cultures. Similar re-
sults were observed with AR staining, in which the staining in the CC
cultures reached a plateau on day 28 whilst it has steadily progressed in
the SEC cultures.
The mRNA expression proﬁles of genes that code for other non-
collagenous proteins with important roles in osteogenesis, i.e. osteo-
pontin (SPP1), osteonectin (SPARC) and osteocalcin (BGLAP) also
conﬁrmed the osteogenesis-promoting eﬀect of the aragonite scaﬀolds
on BM-MSCs. SPP1 codes for one of the most predominant non-col-
lagenous proteins in bone ECM produced by osteoblasts, and it also
promotes cell adhesion to the bone surface (Sodek et al., 2000). We
detected an upregulation of SPP1 28 days post-seeding in the presence
of the scaﬀolds compared to day 7, which correlates well with data
available in the literature (Beck et al., 2000; Foo et al., 2008). The
expression of SPARC, a non-structural glycoprotein secreted by osteo-
blasts was massively decreased by day 28 in SEC cultures compared to
CC cultures. This protein binds calcium in bone, has an aﬃnity for
collagen and is also involved in cell-matrix interactions (Ram et al.,
2015). Osteonectin expression was found to be strongly upregulated in
a coral graft culture system during osteogenic diﬀerentiation of mouse
MSCs (Puvaneswary et al., 2013). However, given that SPARC is more
strongly expressed during the early stages of osteogenesis (i.e. during
the proliferative and matrix deposition periods) (Beck et al., 2000;
Kulterer et al., 2007), our results may suggest that in the presence of the
scaﬀold, osteogenic diﬀerentiation was accelerated relative to the
control cultures. As cells progressed towards the later stages of osteo-
genic diﬀerentiation, SPARC was already downregulated by day 28.
A low expression of BGLAP (osteocalcin) can be explained by the
fact that it is produced mainly by mature osteoblasts during the mi-
neralisation phase, although its transcripts can also be detected during
the earlier stages of osteogenesis, such as proliferation (Beck et al.,
2000; Zoch et al., 2016). Nonetheless, a very similar osteocalcin mRNA
expression pattern was observed during the osteogenic induction of
periodontal ligament-derived cells (Choi et al., 2011).
Alkaline phosphatase (ALP), an important marker for bone matrix
mineralisation and is therefore a widely used marker for in vitro os-
teoblastic phenotype characterisation (Fedde, 1992). Its expression re-
mained constant in the SEC cultures.
Osteoblastogenesis and de novo bone formation are deﬁned by four
major phases: lineage commitment, proliferative expansion, synthesis
of primary bone ECM (osteoid), and mineralisation (Javed et al., 2010).
In many cell culture systems, osteoblastic proliferation takes place at
the expense of maturation. Our results suggest that the Agili-C™ scaﬀold
in SEC cultures may uniquely stimulate both proliferation and diﬀer-
entiation compared to the CC cultures. In our study, the proliferation
rate in SEC cultures was higher than in CC cultures up to day 14, when
it was found to be more than 3 times higher in the presence of the
scaﬀold compared to the CC cultures. Proliferation rate returned to
control levels by the end of the 21 days long culturing period, which
Fig. 7. Cell adherence to the calcium phosphate de-
posited layer formed on the aragonite scaﬀold. A. A
cell sending processes to the coral surface (original
magniﬁcation, 1,000×; scale bar, 10 μm). B–C.
Higher magniﬁcation SEM images (original magni-
ﬁcations, B – 2,500×, C – 8,000×; scale bars, B –
10 μm, C – 2 μm) showing cell adherence to the de-
posited calcium phosphate layer. D. Spherical de-
posits (arrow) appeared as early as culturing day 14
on the aragonite scaﬀold (original magniﬁcation,
15,000×; scale bar, 1 μm).
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indicates that the scaﬀolds did not induce abnormal proliferation pat-
tern of BM-MSCs, suggesting its suitability for in vivo clinical applica-
tions. The reduced proliferation rate at later time points, e.g. by day 21
(i.e. in more mature osteogenic cell cultures) can also be regarded as a
sign of progression in diﬀerentiation. Also, the fact that higher numbers
of proliferating cells were located in the close proximity of scaﬀolds as
revealed by PCNA immunocytochemistry in 14-day-old cultures in-
dicates the requirement for interaction between the cells and the sur-
face of the scaﬀold to promote cell division. The observed higher rate of
cell proliferation by the scaﬀold is a sign of its ability to promote os-
teogenesis from the very beginning of the process, when a rapid pro-
liferation of osteoprogenitors is necessary to establish a higher number
of osteoid-secreting late osteoblasts (Javed et al., 2010). Our ﬁndings
show a similar pattern of cell proliferation to basic ﬁbroblast growth
factor (bFGF)-overexpressing bone marrow-derived MSCs reported
earlier (Zheng et al., 2011); however, in that study, MSCs seeded onto
the coral scaﬀolds exhibited lower rates of proliferation compared to
control. A potential diﬀerence that may explain this observation is that
MSCs in our study were cultured in osteogenic diﬀerentiation medium,
whereas Zheng and colleagues cultured the cells in normal DMEM. In a
diﬀerent study, a partially converted, biodegradable coralline hydro-
xyapatite/calcium carbonate composite comprising of a coralline
CaCO3 scaﬀold enveloped by a thin layer of hydroxyapatite also did not
increase the proliferation of hMSCs compared to cells grown on cov-
erslips (Fu et al., 2013). However, when BM-MSCs were seeded onto
native coral CaCO3 substrates, a remarkably similar increase in
proliferation was reported as determined by [3H]-thymidine in-
corporation assay (Fricain et al., 1998).
The mechanism underlying the current study may involve surface
modiﬁcation or deposition on the scaﬀold, resulting in about 2% of the
superﬁcial layer mass being changed into calcium phosphate during
conversion and/or deposition (see Fig. 6). At the same time, the cells
seem to preferentially attach to these deposits and are associated with
the formation of spherical calcium phosphate depositions similar in
appearance to hydroxyapatite (See Fig. 7).
Taken together, these results clearly demonstrate the osteogenic
capacity of the scaﬀold, in addition to the mitogenic eﬀect on BM-
MSCs. The deposition of calcium phosphate on the Agili-C™ scaﬀold
surface supports observations in earlier studies reporting direct osteo-
conduction by aragonite scaﬀolds.
Fig. 8. A. Proliferation rates detected by 3H-thymidine incorporation of CC and
SEC cultures maintained in osteogenic medium for 3, 7, 14 and 21 days.
Statistically signiﬁcant proliferation rates were detected on days 3, 7 and 14
compared to control cultures (CC) (n = 3; *P < 0.05). B. Proliferating Cell
Nuclear Antigen (PCNA) immunocytochemistry of CC and SEC cultures. The
number of dividing cells is higher in the proximal zone of the scaﬀold or its
fragments (SEC, position of the removed implant fragments were labelled by
asterisks). Representative photomicrographs out of three independent experi-
ments are shown. Original magniﬁcation, 10×. Scale bar, 200 μm for all
images. CC-Control culture; SEC-Scaﬀold Exposed Culture.
Fig. 9. Relative mRNA expression levels of the osteogenic marker genes alka-
line phosphatase (ALP), bone gamma-carboxyglutamate (BGLAP; osteocalcin),
runt-related transcription factor 2 (RUNX2), osteonectin (SPARC) and osteo-
pontin (SPP1) on days 7 and 28 using RT-qPCR. Relative gene expression levels
were normalized to PPIA (cyclophilin-A). Asterisks (*) mark signiﬁcant changes
in gene expression level compared to day 7 (*P < 0.05; **P < 0.01); hash
signs (#) mark signiﬁcant changes compared to the control (CC) within the
same measurement day (#P < 0.05; ##P < 0.01. Data shown are re-
presentative of three independent experiments. F. Heatmap of the expressed
genes in human BM-MSCs cultured with or without coral-derived aragonite
scaﬀold. Diﬀerent expression levels of the transcripts of the genes related to
osteogenesis are shown. The cluster analysis and dendrogram show the diﬀer-
ence between the transcripts and the sample groups. Blue and red colours in-
dicate high and low expression levels, respectively. (Values represent the re-
lative expression level of the genes). (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the Web version of this
article.)
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5. Conclusions
Under appropriate conditions which favour osteogenesis, these re-
sults indicate that the Agili-C™ scaﬀold can promote the direct adhe-
sion, proliferation and diﬀerentiation of human BM-MSCs. The me-
chanism of ECM formation may involve scaﬀold surface modiﬁcation
with layering of calcium phosphate deposits supporting osteoconduc-
tion (possibly even osteotransduction). As hMSC cultures were main-
tained in osteogenic media over the entire period of the study, the
presence of the scaﬀolds markedly augmented the osteogenesis-pro-
moting eﬀect of these culturing conditions, enhanced proliferation as
well as the osteogenic diﬀerentiation of BM-MSCs at both the molecular
and histological levels. Based on these results we can conclude that this
acellular scaﬀold is applicable for bone remodelling to promote a faster
bone tissue formation in osteochondral lesions or bone fusions and
serves as an excellent scaﬀold for colonisation and osteogenic diﬀer-
entiation of bone marrow derived mesenchymal stem cells.
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